Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Other Non-Current Assets (2021 - 2022)

Marker Therapeutics (MRKR) has disclosed Other Non-Current Assets for 3 consecutive years, with $585840.0 as the latest value for Q4 2022.

  • Quarterly Other Non-Current Assets fell 46.74% to $585840.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $585840.0 through Dec 2022, down 46.74% year-over-year, with the annual reading at $585840.0 for FY2022, 46.74% down from the prior year.
  • Other Non-Current Assets for Q4 2022 was $585840.0 at Marker Therapeutics, up from $200000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.1 million in Q4 2021, with the low at $200000.0 in Q1 2022.